CAS 668467-91-2
:1H-Indol-2,3-diona, 5-cloro-1-[(2,5-diclorofenil)metil]-,3-(O-acetiloxima)
Ref: IN-DA00FBJ5
1gA consultar250mgA consultar1mg52,00€5mg97,00€10mg131,00€25mg168,00€50mg281,00€100mg503,00€LDN-57444
CAS:LDN-57444 is a reversible, competitive proteasome Uch-L1 inhibitor(IC50=0.88 μM) .Fórmula:C17H11Cl3N2O3Pureza:97.8% - 99.96%Forma y color:Yellow SolidPeso molecular:397.64LDN-57444
CAS:3-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)indolin-2-oneFórmula:C17H11Cl3N2O3Pureza:98%Peso molecular:397.643-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)indolin-2-one
CAS:Pureza:98%Peso molecular:397.6400146LDN-57444
CAS:LDN-57444 is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and inhibits its activation. LDN-57444 is being developed for the treatment of squamous cell carcinoma, which is a type of skin cancer. The drug has been shown to inhibit tumor growth in animal models by inhibiting body formation, promoting autophagy, and reducing mitochondrial membrane potential. LDN-57444 has also been shown to inhibit the proliferation of human cancer cells in vitro and decrease cardiac arrhythmias. LDN-57444 binds to EGFR with a hydroxyl group on its structure that interacts with the EGFR's active site. This binding prevents EGFR from activating downstream signaling pathways, such as those involving phosphatidylinositol 3-kinase (PI3K) and Akt kinase, which are involved in cell proliferation and survival.
Fórmula:C17H11Cl3N2O3Pureza:Min. 95%Peso molecular:397.64 g/mol






